Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
Innovation and Product Development news
(page 33)
19 February 2026
Carbon Neutral Fuels Chooses Johnson Matthey, Honeywell for UK E-Fuels Project
Project Starling will convert CO2 and water into sustainable aviation fuel, aiming for 25,000 tons annually by 2031, using advanced technologies for significant emissions savings.
19 February 2026
Johnson & Johnson's Rybrevant Faspro™ Shows 56% Response Rate in First-Line Head and Neck Cancer
The OrigAMI-4 study shows amivantamab with immunotherapy offers durable antitumor activity in recurrent/metastatic head and neck cancer, improving outcomes over current treatments.
19 February 2026
BASF Introduces Circalo for Low Carbon Ethanol Production
Circalo connects farmers and ethanol producers to reduce carbon intensity, aligning with Section 45Z, using xarvio tools for data verification and compliance.
19 February 2026
BASF Launches AdBlue GE Using 100% Green Electricity
AdBlue GE is made with renewable electricity, reducing CO2 emissions. It matches conventional AdBlue in quality and performance. Initial launch in Switzerland, with plans for wider European rollout.
19 February 2026
Statkraft's Former Employees Advance Biofuel Tech at Tofte
Statkraft shifts focus to core technologies, transferring biofuel expertise to a new company led by former employees, aiming to commercialize HTL technology for emissions reduction.
19 February 2026
Merck Reports Positive Phase 3 Trial Results for ENFLONSIA in High-Risk Infants and Children
ENFLONSIA shows consistent safety and efficacy in high-risk infants over two RSV seasons, supporting expanded use for children under 2.
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
19 February 2026
INEOS Secures €300M French Grant to Decarbonise Lavera Site
The investment cuts CO2 by 331,000 tonnes annually, secures jobs, boosts competitiveness, and supports France's industrial and climate goals through electrification and carbon capture.
19 February 2026
Asahi Kasei's Thin-Film Hall Elements Earn IEEE Milestone Recognition
Thin-film Hall elements, launched in 1983, revolutionized magnetic sensors, enhancing electronics and energy efficiency, with over 50 billion units shipped globally.
18 February 2026
AFC Energy permitted to export and sell low‑carbon hydrogen from Dunsfold pilot plant
Environment Agency approved export/sale of low‑carbon ISO 14687 D hydrogen from Dunsfold pilot (up to 300kg/day); JV with ICL advancing Hy‑5 rollout and permitting for larger sites.
18 February 2026
Asahi Kasei Pharma and Alchemedicine: AK1960 enters Phase I for refractory diseases
AK1960, a novel ETA receptor antagonist with a new core structure, shows high ETA selectivity and kidney-disease efficacy in animals and has advanced to Phase I for refractory diseases.
18 February 2026
Asahi Kasei Pharma Advances AK1960 to Phase I for Refractory Diseases
AK1960, an ETA receptor antagonist, enters Phase I trials for refractory diseases, leveraging Alchemedicine's HiSAP™ platform and partnerships with Calliditas and Veloxis.
18 February 2026
Johnson & Johnson's RYBREVANT FASPRO™ Gains FDA Breakthrough Status for Advanced Head and Neck Cancer
FDA grants Breakthrough Therapy Designation to RYBREVANT FASPRO™ for HPV-unrelated head and neck cancer after platinum-based chemotherapy and PD-1/PD-L1 inhibitor.
18 February 2026
PureCycle and TOPPAN Partner for Sustainable Recycled Packaging Solutions
They developed a snack bar wrapper with 30% recycled content, targeting thermoforming applications to meet regulatory demands without compromising safety or performance.
18 February 2026
Merck and Mayo Clinic Collaborate on AI-Driven Drug Discovery
The collaboration combines clinical data and AI to enhance drug discovery, focusing on gastroenterology, dermatology, and neurology for tailored therapies.
18 February 2026
Lilly's Taltz and Zepbound Show Superior Results in Psoriasis and Obesity Trial
Taltz and Zepbound together improved skin clearance and weight loss in psoriasis patients with obesity, outperforming Taltz alone in a Phase 3b trial.
18 February 2026
Asahi Kasei Pharma Begins Phase I Study of AK1960
AK1960, a selective endothelin A receptor antagonist, shows promise for treating refractory kidney diseases, aligning with R&D strategies for unmet medical needs.
18 February 2026
NEXTCHEM Secures Licensing Deal in China for NX CONSER™ Technologies
The technologies will enable efficient co-production of BDO and DMS, supporting biopolymer production with improved cost, energy efficiency, and sustainability.
17 February 2026
Perstorp Expands Liquid Cooling Solutions for Data Centers
Perstorp introduces Synplate™ and expands Synmerse™ for efficient, safe liquid cooling in data centers, enhancing performance and sustainability.
17 February 2026
Genmab Releases 2025 Annual Report
The report highlights 2025 achievements, financials, and 2026 outlook, including revenue growth, strategic acquisitions, and regulatory approvals.
17 February 2026
Stahl Wins 2025 adiFORMULATOR Award from adidas
Stahl's commitment to safer formulations and ZDHC compliance earns recognition, highlighting its role in advancing sustainable practices in the chemical industry.
17 February 2026
Neste and World Fuel Services Expand SAF Availability at 100+ European Airports
The five-year agreement supports regulatory compliance and boosts SAF supply, leveraging World Fuel's network and Neste's production capabilities.
17 February 2026
Alchemedicine and Asahi Kasei Pharma License Agreement for HiSAP Compounds
Asahi Kasei Pharma gains global rights to develop and commercialize HiSAP compounds, with Alchemedicine receiving up to ¥41.3 billion in payments and royalties.
16 February 2026
Kao selected by NEDO to build saccharification enzyme supply platform
Selected by NEDO to build a saccharification enzyme supply platform to convert unused biomass into sugars for bioproducts including bioethanol and SAF.
16 February 2026
Horse Powertrain and Repsol Develop Efficient Hybrid Powertrain with Renewable Gasoline
The new hybrid powertrain achieves 44.2% efficiency, cuts fuel use by 40%, and reduces CO2 emissions using 100% renewable gasoline, supporting a technology-neutral approach to decarbonization.
16 February 2026
Geoinform Ltd. and Baker Hughes Form Strategic Partnership
The partnership aims to enhance operational efficiency with innovative technologies, covering services, asset maintenance, and professional training in the energy sector.
16 February 2026
Moeve and ADA Form Quantum Computing Alliance
The alliance aims to boost quantum tech in Andalusia, enhancing energy efficiency and security, with IBM as a tech partner and Ayesa collaborating.
16 February 2026
Lilly's Retevmo Shows Event-Free Survival Benefit in Early-Stage RET Fusion-Positive Lung Cancer
Selpercatinib significantly reduces disease recurrence risk in early-stage RET fusion-positive NSCLC. Safety profile aligns with previous trials. Detailed results pending.
16 February 2026
SPIE Joins IPAI to Boost AI Expertise
SPIE joins IPAI to enhance AI capabilities, focusing on practical solutions in energy and communications, while promoting human-centered AI and collaboration.
16 February 2026
UBE Invests in Immaterial Ltd
Investment supports commercialization of CO₂ capture tech using Metal-Organic Frameworks, aiming to reduce industrial decarbonization costs and meet global demand for sustainable solutions.
16 February 2026
Roche Reports Positive Phase III Results for Gazyva in Membranous Nephropathy
Phase III study shows Gazyva achieves higher remission rates in membranous nephropathy, with safety consistent and no new signals. Data to be shared with health authorities.
← Previous
Next →
